Comprehensive Immune Response Profiling for Immuno-Oncology Programs
In immuno-oncology, understanding cellular immune responses is critical to evaluating therapeutic efficacy and safety. Accelevir provides immune response profiling using intracellular cytokine staining (ICS), ELISpot, and cytokine multiplex assays to quantify T cell, NK cell, and myeloid responses in preclinical and clinical studies.
Technical Capabilities:
- ICS via multiparameter flow cytometry for Th1/Th2 balance and polyfunctionality.
- ELISpot for high-sensitivity detection of antigen-specific T cells.
- Luminex and ELISA panels for multiplex cytokine/chemokine profiling.
- Longitudinal immune monitoring for checkpoint inhibitor and cell therapy trials.
Why Partner with Accelevir:
- Integrated immune profiling with molecular correlates.
- GLP/CLIA-compliant workflows for pivotal trials.